List of Tables
Table 1. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of COG-133
Table 3. Key Players of GZ-402668
Table 4. Key Players of Inebilizumab
Table 5. Key Players of VCE-0032
Table 6. Key Players of Others
Table 7. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Region (2018-2023)
Table 11. Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Region (2024-2029)
Table 13. Progressive Relapsing Multiple Sclerosis Treatment Market Trends
Table 14. Progressive Relapsing Multiple Sclerosis Treatment Market Drivers
Table 15. Progressive Relapsing Multiple Sclerosis Treatment Market Challenges
Table 16. Progressive Relapsing Multiple Sclerosis Treatment Market Restraints
Table 17. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Players (2018-2023)
Table 19. Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Progressive Relapsing Multiple Sclerosis Treatment as of 2022)
Table 20. Ranking of Global Top Progressive Relapsing Multiple Sclerosis Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Progressive Relapsing Multiple Sclerosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Progressive Relapsing Multiple Sclerosis Treatment Product Solution and Service
Table 24. Date of Enter into Progressive Relapsing Multiple Sclerosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Application (2024-2029)
Table 34. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Cognosci Inc Company Detail
Table 50. Cognosci Inc Business Overview
Table 51. Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Product
Table 52. Cognosci Inc Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
Table 53. Cognosci Inc Recent Development
Table 54. Genzyme Corp Company Detail
Table 55. Genzyme Corp Business Overview
Table 56. Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Product
Table 57. Genzyme Corp Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
Table 58. Genzyme Corp Recent Development
Table 59. MedImmune LLC Company Detail
Table 60. MedImmune LLC Business Overview
Table 61. MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Product
Table 62. MedImmune LLC Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
Table 63. MedImmune LLC Recent Development
Table 64. VivaCell Biotechnology Espana SL Company Detail
Table 65. VivaCell Biotechnology Espana SL Business Overview
Table 66. VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Product
Table 67. VivaCell Biotechnology Espana SL Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
Table 68. VivaCell Biotechnology Espana SL Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. COG-133 Features
Figure 4. GZ-402668 Features
Figure 5. Inebilizumab Features
Figure 6. VCE-0032 Features
Figure 7. Others Features
Figure 8. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application: 2022 VS 2029
Figure 10. Clinic Case Studies
Figure 11. Hopital Case Studies
Figure 12. Others Case Studies
Figure 13. Progressive Relapsing Multiple Sclerosis Treatment Report Years Considered
Figure 14. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Players in 2022
Figure 18. Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Progressive Relapsing Multiple Sclerosis Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Progressive Relapsing Multiple Sclerosis Treatment Revenue in 2022
Figure 20. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2018-2029)
Figure 22. United States Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2018-2029)
Figure 26. Germany Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Share by Region (2018-2029)
Figure 34. China Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2018-2029)
Figure 42. Mexico Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Progressive Relapsing Multiple Sclerosis Treatment Market Share by Country (2018-2029)
Figure 46. Turkey Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Cognosci Inc Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023)
Figure 49. Genzyme Corp Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023)
Figure 50. MedImmune LLC Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023)
Figure 51. VivaCell Biotechnology Espana SL Revenue Growth Rate in Progressive Relapsing Multiple Sclerosis Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed